Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Health Catalyst Inc (NASDAQ: HCAT) closed at $6.76 in the last session, down -0.22% from day before closing price of $6.77. In other words, the price has decreased by -$0.22 from its previous closing price. On the day, 0.56 million shares were traded. HCAT stock price reached its highest trading level at $6.88 during the session, while it also had its lowest trading level at $6.5.
Ratios:
We take a closer look at HCAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.18 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.05.
On January 03, 2024, Evercore ISI Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $11.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $14.Barclays initiated its Overweight rating on January 03, 2024, with a $14 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when Llewelyn Linda sold 1,328 shares for $6.57 per share. The transaction valued at 8,725 led to the insider holds 118,536 shares of the business.
LeSueur Daniel sold 5,209 shares of HCAT for $32,224 on Aug 05 ’24. The Chief Operating Officer now owns 150,006 shares after completing the transaction at $6.19 per share. On Aug 05 ’24, another insider, DANIEL LESUEUR, who serves as the Officer of the company, bought 5,209 shares for $6.71 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 408476192 and an Enterprise Value of 349795584. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.36 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 1.168 whereas that against EBITDA is -8.388.
Stock Price History:
Over the past 52 weeks, HCAT has reached a high of $12.69, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is 1.92%, while the 200-Day Moving Average is calculated to be -11.51%.
Shares Statistics:
According to the various share statistics, HCAT traded on average about 534.55K shares per day over the past 3-months and 780460 shares per day over the past 10 days. A total of 58.30M shares are outstanding, with a floating share count of 57.65M. Insiders hold about 4.66% of the company’s shares, while institutions hold 86.08% stake in the company. Shares short for HCAT as of 1722384000 were 2200503 with a Short Ratio of 4.12, compared to 1719532800 on 2067761. Therefore, it implies a Short% of Shares Outstanding of 2200503 and a Short% of Float of 3.74.
